People with hidden pockets of fat in their muscles – similar to so-called marbling in beef – are at a higher risk of dying from heart attacks or heart failure regardless of their body weight, ...

At the same time, heart disease remains the leading cause of death in the U.S., affecting nearly half of adults aged 20 and ...

However, the benefits of beta-blockers in “stiff heart” heart failure are less clear. This condition, also known as heart ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

It’s not yet time to abandon seated BP measurements, but taking a look at supine readings may provide enhanced risk ...

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...